GlassScriptPhysician profile
Thomas T Terramani
NPI 1447344338
$126,487.16
in general payments reported to CMS, 2019-2025
41 companies · $19K in 2025
The $19K reported for 2025 was more than what 94% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,193 · 2020: $21K · 2021: $23K · 2022: $22K · 2023: $22K · 2024: $12K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Royalty Or License: $6,327 · Travel and Lodging: $5,315 · Food and Beverage: $2,596 · Long Term Medical Supply Or Device Loan: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,219.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,529.50 |
| Royalty Or License | $6,326.81 |
| Travel and Lodging | $5,315.35 |
| Food and Beverage | $2,595.69 |
| Long Term Medical Supply Or Device Loan | $114.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novapproach Spine, LLC | $38,390.46 | 2022-2025 | Onelif |
| Aesculap Implant Systems, LLC | $24,321.96 | 2019-2024 | Activl |
| Kyocera Medical Technologies, INC. | $20,588.59 | 2020-2025 | |
| Medical Device Business Services, INC. | $10,832.40 | 2019-2021 | |
| Medtronic, INC. | $9,713.54 | 2021-2025 | Unid_pass, Anteralign Spinal System With Titan Nanolock Surface Technology, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Stryker Corporation | $8,643.01 | 2020-2024 | N/A |
| Integrity Implants INC. | $3,320.52 | 2021-2022 | |
| Surgalign Spine Technologies, INC. | $2,611.80 | 2021-2022 | |
| Depuy Synthes Products, INC. | $2,575.00 | 2019 | |
| Centinel Spine, LLC | $2,356.64 | 2024-2025 | Prodisc L |
| Spinal Elements, INC. | $511.11 | 2019-2024 | |
| Globus Medical, INC. | $480.78 | 2019-2025 | Independence |
| W. L. Gore & Associates, INC. | $299.22 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Depuy Synthes Sales INC. | $225.38 | 2019-2021 | |
| Endologix LLC | $196.48 | 2020 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $194.11 | 2019 | |
| Biotissue Holdings INC. | $137.00 | 2023 | |
| Cook Medical LLC | $119.52 | 2019 | |
| Integra Lifesciences Corporation | $114.40 | 2025 | Micromatrix, Cytal |
| Titan Spine, LLC | $91.91 | 2019 | |
| Spineology INC. | $78.48 | 2019 | |
| Baxter Healthcare | $73.71 | 2020 | |
| Janssen Pharmaceuticals, INC | $73.50 | 2019-2021 | |
| Angiodynamics, INC. | $72.24 | 2020-2023 | Alphavac |
| Medtronic USA, INC. | $69.66 | 2019-2020 | |
| Becton, Dickinson and Company | $41.29 | 2024 | Crosser Iq |
| Smith+Nephew, INC. | $40.76 | 2025 | Collagenase Santyl |
| Seaspine Orthopedics Corporation | $39.98 | 2019 | |
| Pfizer INC. | $37.16 | 2021-2024 | |
| Aroa Biosurgery Incorporated | $33.60 | 2023 | |
| Lemaitre Vascular, INC. | $27.02 | 2025 | Hydro Lemaitre Valvulotome |
| Cardiva Medical, INC. | $22.51 | 2023 | Cardiva Vascade 6/7f Vcs |
| Teleflex LLC | $21.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.16 | 2021 | |
| Tactile Systems Technology INC | $17.88 | 2019 | |
| Humacyte Global, INC. | $17.31 | 2025 | Symvess |
| Abbvie INC. | $17.17 | 2024 | |
| Bard Peripheral Vascular, INC. | $16.90 | 2025 | Rotarexs 6 F X 135 Cm |
| Terumo Medical Corporation | $16.42 | 2022 | |
| Boston Scientific Corporation | $14.63 | 2021 | |
| Bolton Medical INC | $13.95 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$203,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Terramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.